Dexamethasone (Dextenza)

Small molecule

Approvedregulatory verdict

Evidence outlook

Approved: Ocular Inflammation and Pain, Allergic Conjunctivitis

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

track record: Partial signal

Also approved (1)
MO
  • Ocular inflammation and pain following ophthalmic surgery (DEXTENZA)
Product first approved 2022drugdiscoveryonline.com

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 3 (7)
Allergic Conjunctivitis
Ocular Inflammation and Pain
Other / comorbidity
NCT04539548 · Ocular Therapeutix, Inc.
2020-09-04 – 2023-12-21 · Cataract
What this study did
Phase 2/3 (1)
Other / comorbidity
NCT04563559 · Duke University
2020-11 – 2021-11 · Cataract Surgery, Glaucoma Surgery
What this study did
Phase 2 (3)
Allergic Conjunctivitis
NCT02062905 · Ocular Therapeutix, Inc.
2014-03 – 2014-11 · Chronic Allergic Conjunctivitis
What this study did
Ocular Inflammation and Pain
NCT01666210 · Ocular Therapeutix, Inc.
2012-10 – 2013-08 · Ocular Inflammation and Pain
What this study did
Other / comorbidity
NCT02468700 · Ocular Therapeutix, Inc.
2015-01 – 2015-11 · Dry Eye
What this study did
Phase 1/2 (1)
Other / comorbidity
NCT06235567 · Maanasa Indaram, MD
2025-04-11 – 2027-07 · Keratoconus
What this study did
Phase 1 (3)
Other / comorbidity
NCT05620901 · Lejla Vajzovic, MD, FASRS
2023-02-01 – 2025-02-24 · Vitreoretinopathy, Coats' Disease, Exudative Retinopathy, Lattice Degeneration, Retinal Hole, Sickler's Syndrome, Retinal Detachment Rhegmatogenous, Retinal Detachment Exudative, Retinal Detachment Traction
What this study did
NCT04945824 · Ocular Therapeutix, Inc.
2021-06-01 – 2022-11-01 · Healthy
What this study did
NCT04418999 · Illinois College of Optometry
2020-09-01 – 2021-12-31 · Keratoconus, Dry Eye, Allergy
What this study did
Phase 4 (43)
Allergic Conjunctivitis
NCT04708821 · Clinical Research Center of Florida
2021-04-30 – 2021-09-02 · Bilateral Conjunctivitis (Disorder)
What this study did
Other / comorbidity
NCT04371445 · The Cleveland Clinic
2020-06-01 – 2027-12-01 · Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain, Post-Operative Inflammation
What this study did
NCT05626478 · Nicole Fram M.D.
2023-06-01 – 2025-02-05 · Corneal Edema, Corneal Defect, Anterior Chamber Inflammation, Ocular Pain, Corneal Staining, Visual Outcome, CME - Cystoid Macular Edema
What this study did
NCT04527887 · Tufts Medical Center
2020-09-04 – 2024-12-31 · Dry Eye
What this study did
NCT05587231 · Navy Medical Center San Diego
2022-10 – 2024-10 · Steroid Ophthalmic Insert
What this study did
NCT05665270 · Wyse Eyecare
2023-01-30 – 2023-12-15 · Cataract
What this study did
NCT05116345 · Brian Jerkins, MD
2021-11 – 2023-11 · Glaucoma Following Surgery
What this study did
NCT04200651 · The New York Eye Surgery Center
2020-01-13 – 2023-07-12 · Glaucoma, Cataract
What this study did
NCT04351737 · Brandon Eye Associates, PA
2020-07-15 – 2023-05-23 · Pterygium of Both Eyes
What this study did
NCT04168112 · Sight Medical Doctors PLLC
2020-02-12 – 2023-04-05 · Keratoconus, Unstable, Collagen Crosslinking, Postoperative Pain
What this study did
NCT04498468 · Johns Hopkins University
2021-03-16 – 2023-03-03 · Dry Eye
What this study did
NCT04563299 · Retina Vitreous Associates of Florida
2020-12-09 – 2023-02-14 · Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion
What this study did
NCT05143281 · Grene Vision Group
2021-12-13 – 2023-02-01 · Cataract
What this study did
NCT04464629 · Midwest Eye Institute
2020-07-14 – 2023-01-25 · Retinal Detachment
What this study did
NCT04521140 · Nicole Fram M.D.
2020-10-16 – 2023-01-04 · Corneal Edema, Corneal Defect, Corneal Transplant, Penetrating KeratoPlasty, Anterior Chamber Inflammation, Ocular Pain, Intraocular Pressure
What this study did
NCT04479748 · Prism Vision Group
2020-10-01 – 2022-12-12 · Cataract
What this study did
NCT04839549 · Eye Associates of Central Texas
2020-06-06 – 2022-11-29 · Ocular Rosacea
What this study did
NCT05372315 · Iworks Laser and Vision Center
2022-06-15 – 2022-10-31 · Cataract
What this study did
NCT04687800 · Cathleen McCabe MD
2020-12-01 – 2022-10-24 · Cataract
What this study did
NCT05023304 · Vance Thompson Vision
2021-08-23 – 2022-10-01 · Cataract
What this study did
NCT04413253 · Eye Surgeons of Indiana
2020-08-01 – 2022-04-11 · Dry Eye Syndromes
What this study did
NCT04462523 · Patrick R. Oellers, MD
2020-01-03 – 2022-03-31 · Vitreo-Retinal Surgery
What this study did
NCT04362241 · Ophthalmic Consultants of the Capital Region
2020-08-07 – 2022-03 · Retinopathy, Diabetic
What this study did
NCT05100186 · Joseph Kavanagh, MD
2021-11-01 – 2022-02-28 · Cataract
What this study did
NCT04555694 · Thomas Chester, OD
2020-10-01 – 2022-02-16 · Dry Eye
What this study did
NCT04237012 · The Eye Centers of Racine and Kenosha
2019-12-16 – 2021-12-30 · Dry Eye Syndromes
What this study did
NCT04977427 · Baylor Research Institute
2021-08-31 – 2021-12-20 · Cataract Diabetic, Macula Edema
What this study did
NCT04728646 · Massachusetts Eye and Ear Infirmary
2021-09 – 2021-12-13 · Graft Vs Host Disease
What this study did
NCT04863742 · Sight Medical Doctors PLLC
2021-04-26 – 2021-09-30 · Dry Eye Syndromes
What this study did
NCT04549935 · Vance Thompson Vision - MT
2020-09-14 – 2021-08-27 · Patient Preference, Patient Outcomes, Post-Operative Inflammation, Grade of Post-Operative Cystoid Macular Edema, Rate of Post-Operative Cystoid Macular Edema
What this study did
NCT04403516 · Michelle Rhee MD
2020-10-01 – 2021-08-05 · Pterygium
What this study did
NCT04413279 · Eye Surgeons of Indiana
2020-08-01 – 2021-07-01 · Dry Eye Syndromes
What this study did
NCT04530864 · Prism Vision Group
2021-01 – 2021-07 · Dry Eye Disease, Cataract Surgery, Ocular Surface Disease
What this study did
NCT04380857 · William Wiley, MD
2020-06-18 – 2021-06-21 · Post Procedural Infection
What this study did
NCT04658927 · Warrenville Eyecare
2021-01-04 – 2021-05-30 · Meibomian Gland Dysfunction, Evaporative Dry Eye
What this study did
NCT04426734 · New England Retina Associates
2020-07-01 – 2021-03-31 · Non-infectious Anterior Uveitis
What this study did
NCT04592081 · Kerry Assil, MD
2020-08-01 – 2021-03-11 · Post-Surgical Ocular Pain, Post-Surgical Ocular Inflammation
What this study did
NCT04529512 · Nathan Steinle
2021-03 – 2021-03 · Ocular Disease Requiring Surgery
What this study did
NCT04465864 · Wolstan and Goldberg Eye Associates
2020-02-10 – 2021-01-31 · Glaucoma, Primary Open Angle, Cataract
What this study did
NCT04316936 · Silverstein Eye Centers
2019-12-10 – 2020-12-23 · Cataract Surgery
What this study did
NCT04396990 · Vance Thompson Vision
2020-06-08 – 2020-09-28 · Refractive Surgery
What this study did
NCT04281862 · Vance Thompson Vision
2020-01-23 – 2020-05-01 · Refractive Surgery
What this study did

Competitive landscape

This mechanism is crowded: 23 other tracked programmes target it, none of them ahead of this one.

This drug's own stage for Allergic Conjunctivitis: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Dexamethasone (Dextenza): this drugApprovedSmall moleculeGlucocorticoid receptornot yet gradedNo reviewed efficacy summary in this indication
Albuterol / Budesonide (Airsupra)
Approved(overall)
CombinationBeta-2 adrenergic receptor, Glucocorticoid receptor
Reliable signal(overall)
No reviewed efficacy summary in this indication
Beclomethasone (QVAR)
Approved(overall)
Small moleculeGlucocorticoid receptor
Reliable signal(overall)
No reviewed efficacy summary in this indication
Betamethasone Dipropionate Emollient Spray (Sernivo)
Approved(overall)
Small moleculeGlucocorticoid receptor
not yet graded(overall)
No reviewed efficacy summary in this indication
Budesonide (Entocort EC)
Approved(overall)
Small moleculeGlucocorticoid receptor
Weak signal(overall)
No reviewed efficacy summary in this indication
Budesonide (Ortikos)
ApprovedUS marketing discontinued (overall)
—Glucocorticoid receptor
not yet graded(overall)
No reviewed efficacy summary in this indication
Budesonide (targeted-Release) (TARPEYO / Nefecon)
Approved(overall)
Small moleculeGlucocorticoid receptor
Reliable signal(overall)
No reviewed efficacy summary in this indication
Budesonide (Uceris Rectal Foam)
Approved(overall)
Small moleculeGlucocorticoid receptor
Reliable signal(overall)
No reviewed efficacy summary in this indication
Budesonide MMX (Uceris)
Approved(overall)
Small moleculeGlucocorticoid receptor
Partial signal(overall)
No reviewed efficacy summary in this indication
Ciclesonide (Alvesco)
Approved(overall)
Small moleculeGlucocorticoid receptor
Reliable signal(overall)
No reviewed efficacy summary in this indication
Dexamethasone
Approved(overall)
Small moleculeGlucocorticoid receptor
not yet graded(overall)
No reviewed efficacy summary in this indication
Fluticasone Furoate (Arnuity Ellipta)
Approved(overall)
Small moleculeGlucocorticoid receptor
Reliable signal(overall)
No reviewed efficacy summary in this indication
Fluticasone Furoate / Umeclidinium / Vilanterol (Trelegy Ellipta)
Approved(overall)
Small moleculeMuscarinic acetylcholine receptor (M3), Beta-2 adrenergic receptor, Glucocorticoid receptor, Glucocorticoid receptor / Beta-2 adrenergic receptor / Muscarinic M3 receptor (ICS/LABA/LAMA triple combination)
Reliable signal(overall)
No reviewed efficacy summary in this indication
Fluticasone Furoate / Vilanterol (Breo Ellipta)
Approved(overall)
Small moleculeBeta-2 adrenergic receptor, Glucocorticoid receptor, Glucocorticoid receptor / Beta-2 adrenergic receptor
Reliable signal(overall)
No reviewed efficacy summary in this indication
Fluticasone Propionate
Approved(overall)
Small moleculeGlucocorticoid receptor
not yet graded(overall)
No reviewed efficacy summary in this indication
Fluticasone Propionate / Salmeterol (Advair HFA)
Approved(overall)
CombinationGlucocorticoid receptor / Beta-2 adrenergic receptor, Beta-2 adrenergic receptor, Glucocorticoid receptor
Partial signal(overall)
No reviewed efficacy summary in this indication
Halobetasol Propionate Foam (Lexette)
ApprovedUS marketing discontinued (overall)
Small moleculeGlucocorticoid receptor
Reliable signal(overall)
No reviewed efficacy summary in this indication
Halobetasol Propionate Lotion (Bryhali)
Approved(overall)
Small moleculeGlucocorticoid receptor
Partial signal(overall)
No reviewed efficacy summary in this indication
Hydrocortisone (Cortenema)
Approved(overall)
Small moleculeGlucocorticoid receptor
not yet graded(overall)
No reviewed efficacy summary in this indication
Hydrocortisone Acetate (Cortifoam)
Approved(overall)
Small moleculeGlucocorticoid receptor
not yet graded(overall)
No reviewed efficacy summary in this indication
Relacorilant (Lifyorli)
Approved(overall)
Small moleculeGlucocorticoid receptor
Partial signal(overall)
No reviewed efficacy summary in this indication
Lodotra (Rayos)
US approval withdrawn(overall)
—Glucocorticoid receptor
Weak signal(overall)
No reviewed efficacy summary in this indication
Freneslerbart / MevonlerbartPhase 3Monoclonal antibodyFel d 1 (major cat allergen protein)not yet gradedNo reviewed efficacy summary in this indication
ReproxalapPhase 3Small moleculeReactive aldehyde species (RASP)Partial signalFeatured results are non-efficacy only in this race
Dazucorilant
Phase 2(overall)
Small moleculeGlucocorticoid receptor
not yet graded(overall)
No reviewed efficacy summary in this indication
Miricorilant
Phase 2(overall)
Small moleculeGlucocorticoid receptor
Partial signal(overall)
No reviewed efficacy summary in this indication

Upcoming events

(2 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Dexamethasone (Dextenza) to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (1)
December 2026 (1)
Phase 1/2KeratoconusEnrolling by invitation
Est. primary completion 2026-12 · NCT06235567 · CT.gov ↗
What to watch
2027 (1)
December 2027 (1)
Phase 4Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain, Post-Operative InflammationRecruiting
Est. primary completion 2027-12-01 · NCT04371445 · CT.gov ↗
What to watch

See the full readout calendar ↗